Published in Clin Exp Immunol on May 01, 1982
SLE like syndrome and functional deficiency of C1q in members of a large family. Clin Exp Immunol (1984) 0.96
The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report. Pediatr Rheumatol Online J (2013) 0.75
The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science (1953) 9.02
Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology (1970) 6.89
Activation of the alternate pathway of human complements by rabbit cells. J Immunol (1974) 5.59
Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol (1971) 5.06
CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS. J Immunol (1963) 3.35
Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc (1973) 2.56
Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence. J Immunol (1963) 2.51
C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med (1971) 2.43
Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC). Clin Exp Immunol (1979) 1.74
Complement-immunoglobulin relation: deficiency of C'1q associated with impaired immunoglobulin G synthesis. Science (1969) 1.67
C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. J Immunol (1979) 1.63
Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus. J Clin Invest (1972) 1.45
Complement fixing abilities of IgA myeloma proteins and their fragments: the activation of complement through the classical pathway. Immunochemistry (1976) 1.11
A new method for the preparation of EAC14 cell with human or guinea-pig serum. J Immunol Methods (1974) 1.07
A genetic defect of the C1q subcomponent of complement associated with childhood (immune complex) nephritis. N Engl J Med (1980) 1.04
Skin lesions, angio-oedema, and hypocomplementaemia. Lancet (1974) 0.99
A rosette assay for the determination of C 1 q receptor-bearing cells. Eur J Immunol (1979) 0.98
Familial C1q deficiency associated with renal and cutaneous disease. Clin Exp Immunol (1981) 0.97
Low molecular weight C1q-precipitins in hypocomplementemic vasculitis-urticaria syndrome: partial purification and characterization as immunoglobulin. J Immunol (1978) 0.94
C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis. Am J Med (1976) 0.85
STUDIES ON THE FOURTH COMPONENT OF COMPLEMENT. I. TITRATION OF THE FOURTH COMPONENT OF COMPLEMENT IN HUMAN SERUM. Biken J (1964) 0.82
A case of selective Clq deficiency. Turk J Pediatr (1979) 0.81
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14
Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay. J Mol Biol (1990) 4.78
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes (2000) 4.55
Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med (1969) 3.87
Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A (1982) 3.75
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27
Shared viral antigen of mammalian leukaemia viruses. Nature (1970) 2.84
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol (1997) 2.82
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res (1992) 2.72
Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62
Occurrence of natural antibody to the G (gross) leukemia antigen in mice. Cancer Res (1966) 2.57
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2. J Exp Med (1973) 2.52
Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg (2000) 2.49
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia. Virology (1978) 2.37
TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A (1996) 2.31
Progress in thermal comfort research over the last twenty years. Indoor Air (2013) 2.24
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J (2001) 2.23
Sequence analysis of the florfenicol resistance gene encoded in the transferable R-plasmid of a fish pathogen, Pasteurella piscicida. Microbiol Immunol (1996) 2.17
Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice. J Natl Cancer Inst (1968) 2.17
Construction of a human full-length cDNA bank. Gene (1994) 2.10
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene (1995) 2.05
Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol (1999) 2.04
Detection of resistance factors in fish pathogen Aeromonas liquefaciens. J Gen Microbiol (1971) 1.88
Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst (1968) 1.84
New visual markers of antibody for electron microscopy. Nature (1969) 1.83
Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun (1990) 1.80
Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res (1994) 1.80
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc Natl Acad Sci U S A (1999) 1.78
Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med (2000) 1.77
Chemical and immunological studies on mycobacterial polysaccharides. 1. Purification and properties of polysaccharides from human tubercle bacilli. J Bacteriol (1968) 1.74
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Detection of cerebrospinal fluid leakage: initial experience with three-dimensional fast spin-echo magnetic resonance myelography. Acta Radiol (2008) 1.63
Detection of H-2 antigens on mouse spermatozoa by the cytotoxicity test. Nature (1970) 1.62
Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy. J Exp Med (1972) 1.62
[Relationship between chilliness of the limbs and daily-life conditions in young females]. Nihon Eiseigaku Zasshi (1995) 1.57
Cell surface antigens: serial sectioning of single cells as an approach to topographical analysis. Science (1971) 1.56
Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members. Proc Natl Acad Sci U S A (2001) 1.54
Presence of antigen common to avian tumor viral envelope antigen in normal chick embryo cells. Virology (1973) 1.54
Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection. J Exp Med (1985) 1.52
Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest (1992) 1.52
Ulcerative colitis with skip lesions at the mouth of the appendix: a clinical study. Am J Gastroenterol (1998) 1.49
Nucleotide sequence analysis of the class G tetracycline resistance determinant from Vibrio anguillarum. Microbiol Immunol (1992) 1.48
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Operation for type A aortic dissection: introduction of retrograde cerebral perfusion. Ann Thorac Surg (1995) 1.47
MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha. J Biol Chem (1996) 1.45
Empyema and mediastinitis complicating retropharyngeal abscess. Thorax (1994) 1.45
Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res (1996) 1.45
Anbtibiotics and drug resistance in animals. R factors related to fish culturing. Ann N Y Acad Sci (1971) 1.44
Non-familial olivopontocerebellar atrophy combined with late onset Alzheimer's disease: a clinico-pathological case report. J Neurol Sci (1998) 1.44
Persistent abnormalities of the metabolism of an oral glucose load in insulin-treated type I diabetics. Metabolism (1989) 1.43
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest (1988) 1.42
Efficacy of directional coronary atherectomy before stent implantation for coronary ostial lesions. J Invasive Cardiol (2000) 1.42
Cloning and functional expression of a cytochrome P450 cDNA encoding 2-hydroxyisoflavanone synthase involved in biosynthesis of the isoflavonoid skeleton in licorice. Plant Physiol (1999) 1.40
Raltegravir can be used safely in HIV-1-infected patients treated with warfarin. Int J STD AIDS (2012) 1.40
Bilirubin adsorption therapy and subsequent liver transplantation cured severe bilirubin encephalopathy in a long-term survival patient with Crigler-Najjar disease type I. Intern Med (2000) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Probable Langevin-like director reorientation in an interface-induced disordered SmC*-like state of liquid crystals characterized by frustration between ferro- and antiferroelectricity. Phys Rev Lett (2001) 1.39
Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst (1974) 1.38
Hyaluronan serves a novel role in airway mucosal host defense. FASEB J (2001) 1.38
Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer (1998) 1.37
A novel pathogenesis of megacolon in Ncx/Hox11L.1 deficient mice. J Clin Invest (1997) 1.37
Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol (1999) 1.36
Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB-3T3. Proc Natl Acad Sci U S A (1973) 1.36
Detection of R factors in naturally occurring Vibrio anguillarum strains. Antimicrob Agents Chemother (1974) 1.35
Anaphylactic symptoms due to chlorhexidine gluconate. Arch Dermatol (1989) 1.33
Movement of single myosin filaments and myosin step size on an actin filament suspended in solution by a laser trap. Biophys J (1994) 1.33
Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int (2006) 1.32
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett (2001) 1.31
Wild-type gross leukemia virus: classification of soluble antigens (GSA). J Virol (1972) 1.31
Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med (1987) 1.31
Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun (2001) 1.31
Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat (1992) 1.30
Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis. J Clin Microbiol (2000) 1.30
Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4. J Immunol (1993) 1.29
Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol (2002) 1.29
The relationship of the hemolytic activity of active C'1s to its TAMe esterase action: a new method of purification and assay. J Immunol (1969) 1.28
Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL male 1 cells. J Natl Cancer Inst (1975) 1.28
Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation. J Natl Cancer Inst (1972) 1.28
The transposon-like structure of IS26-tetracycline, and kanamycin resistance determinant derived from transferable R plasmid of fish pathogen, Pasteurella piscicida. Microbiol Immunol (1994) 1.28
Detection of R factors in naturally occurring Aeromonas salmonicida strains. Appl Microbiol (1971) 1.26
Evolutionary implications of the mosaic pyrimidine-biosynthetic pathway in eukaryotes. Gene (2000) 1.26
Effects of music during exercise on RPE, heart rate and the autonomic nervous system. J Sports Med Phys Fitness (2006) 1.26
Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin. Clin Exp Immunol (1984) 1.25
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Clin Cancer Res (1998) 1.24
Reaction mechanisms of beta1H globulin. Int Arch Allergy Appl Immunol (1978) 1.24
Iron-regulated haemolysin gene from Edwardsiella tarda. Mol Microbiol (1997) 1.24
The N- and C-terminal regions of RBP-J interact with the ankyrin repeats of Notch1 RAMIC to activate transcription. Nucleic Acids Res (2001) 1.24
Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg (2001) 1.22
Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun (1994) 1.22
Diversity of envelope antigens on murine type-C RNA viruses. J Natl Cancer Inst (1974) 1.20
The structure of southern bean mosaic virus at 22.5 a resolution. Virology (1976) 1.20
Temperature-modulated platelet and lymphocyte interactions with poly(N-isopropylacrylamide)-grafted surfaces. Biomaterials (1995) 1.20